• Je něco špatně v tomto záznamu ?

Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies

C. Ge, S. Peters, A. Olsson, L. Portengen, J. Schüz, J. Almansa, T. Behrens, B. Pesch, B. Kendzia, W. Ahrens, V. Bencko, S. Benhamou, P. Boffetta, B. Bueno-de-Mesquita, N. Caporaso, D. Consonni, P. Demers, E. Fabiánová, G. Fernández-Tardón, J....

. 2020 ; 202 (3) : 412-421. [pub] 20200801

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20027954

Rationale: Millions of workers around the world are exposed to respirable crystalline silica. Although silica is a confirmed human lung carcinogen, little is known regarding the cancer risks associated with low levels of exposure and risks by cancer subtype. However, little is known regarding the disease risks associated with low levels of exposure and risks by cancer subtype.Objectives: We aimed to address current knowledge gaps in lung cancer risks associated with low levels of occupational silica exposure and the joint effects of smoking and silica exposure on lung cancer risks.Methods: Subjects from 14 case-control studies from Europe and Canada with detailed smoking and occupational histories were pooled. A quantitative job-exposure matrix was used to estimate silica exposure by occupation, time period, and geographical region. Logistic regression models were used to estimate exposure-disease associations and the joint effects of silica exposure and smoking on risk of lung cancer. Stratified analyses by smoking history and cancer subtypes were also performed.Measurements and Main Results: Our study included 16,901 cases and 20,965 control subjects. Lung cancer odds ratios ranged from 1.15 (95% confidence interval, 1.04-1.27) to 1.45 (95% confidence interval, 1.31-1.60) for groups with the lowest and highest cumulative exposure, respectively. Increasing cumulative silica exposure was associated (P trend < 0.01) with increasing lung cancer risks in nonsilicotics and in current, former, and never-smokers. Increasing exposure was also associated (P trend ≤ 0.01) with increasing risks of lung adenocarcinoma, squamous cell carcinoma, and small cell carcinoma. Supermultiplicative interaction of silica exposure and smoking was observed on overall lung cancer risks; superadditive effects were observed in risks of lung cancer and all three included subtypes.Conclusions: Silica exposure is associated with lung cancer at low exposure levels. An exposure-response relationship was robust and present regardless of smoking, silicosis status, and cancer subtype.

Cancer Epidemiology Unit Department of Medical Sciences University of Turin and CPO Piemonte Torino Italy

Center for Research in Epidemiology and Population Health Team Exposome and Heredity Inserm Unit 1018 University Paris Saclay Villejuif France

Consiglio Nazionale delle Ricerche Istituto per la Ricerca e l'Innovazione Biomedica Palermo Italy

Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

Faculty of Health Sciences Palacky University Olomouc Czech Republic

Inserm Unit 1018 Villejuif France

Institut für Medizinische Informatik Biometrie Epidemiologie Ludwig Maximilians Universität Munich Germany Institut für Epidemiologie Deutsches Forschungszentrum für Gesundheit und Umwelt Neuherberg Germany

Institute and Outpatient Clinic for Occupational Social and Environmental Medicine Inner City Clinic University Hospital of Munich and Institute of Epidemiology Helmholtz Zentrum München German Research Center for Environmental Health Neuherberg Germany Comprehensive Pneumology Center Munich Member of the German Center for Lung Research Munich Neuherberg Germany

Institute for Medical Informatics Biometry and Epidemiology University of Duisburg Essen Essen Germany

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance Institute of the Ruhr University Bochum Germany

Institute for Risk Assessment Sciences Utrecht University Utrecht the Netherlands

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

International Agency for Research on Cancer Lyon France

Leibniz Institute for Prevention Research and Epidemiology Bremen Institute for Prevention Research and Social Medicine Bremen Germany

Masaryk Memorial Cancer Institute Brno Czech Republic

National Cancer Institute Bethesda Maryland

National Institute of Public Health Bucharest Romania

National Public Health Center Budapest Hungary

Occupational Cancer Research Centre Cancer Care Ontario Toronto Ontario Canada

Regional Authority of Public Health Banská Bystrica Slovakia Faculty of Health Catholic University Ružomberok Slovakia

Roy Castle Lung Cancer Research Programme Cancer Research Centre University of Liverpool Liverpool United Kingdom

Russian Cancer Research Centre Moscow Russia

Spanish Consortium for Research on Epidemiology and Public Health Faculty of Medicine University of Oviedo Oviedo Spain

The Institute of Environmental Medicine Karolinska Institute Stockholm Sweden

The M Sklodowska Curie National Research Institute of Oncology Warsaw Poland

The National Institute for Public Health and Environmental Protection Bilthoven the Netherlands

The Nofer Institute of Occupational Medicine Lodz Poland

Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York Department of Medical and Surgical Sciences University of Bologna Bologna Italy

Unità di epidemiologia Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

Université de Rennes 1 Inserm Unit 1085 École des hautes études en santé publique Pointe à Pitre France

University of Montreal Hospital Research Centre University of Montreal Montreal Quebec Canada

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027954
003      
CZ-PrNML
005      
20210114152702.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1164/rccm.201910-1926OC $2 doi
035    __
$a (PubMed)32330394
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ge, Calvin $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
245    10
$a Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies / $c C. Ge, S. Peters, A. Olsson, L. Portengen, J. Schüz, J. Almansa, T. Behrens, B. Pesch, B. Kendzia, W. Ahrens, V. Bencko, S. Benhamou, P. Boffetta, B. Bueno-de-Mesquita, N. Caporaso, D. Consonni, P. Demers, E. Fabiánová, G. Fernández-Tardón, J. Field, F. Forastiere, L. Foretova, P. Guénel, P. Gustavsson, V. Ho, V. Janout, KH. Jöckel, S. Karrasch, MT. Landi, J. Lissowska, D. Luce, D. Mates, J. McLaughlin, F. Merletti, D. Mirabelli, N. Plato, H. Pohlabeln, L. Richiardi, P. Rudnai, J. Siemiatycki, B. Świątkowska, A. Tardón, HE. Wichmann, D. Zaridze, T. Brüning, K. Straif, H. Kromhout, R. Vermeulen,
520    9_
$a Rationale: Millions of workers around the world are exposed to respirable crystalline silica. Although silica is a confirmed human lung carcinogen, little is known regarding the cancer risks associated with low levels of exposure and risks by cancer subtype. However, little is known regarding the disease risks associated with low levels of exposure and risks by cancer subtype.Objectives: We aimed to address current knowledge gaps in lung cancer risks associated with low levels of occupational silica exposure and the joint effects of smoking and silica exposure on lung cancer risks.Methods: Subjects from 14 case-control studies from Europe and Canada with detailed smoking and occupational histories were pooled. A quantitative job-exposure matrix was used to estimate silica exposure by occupation, time period, and geographical region. Logistic regression models were used to estimate exposure-disease associations and the joint effects of silica exposure and smoking on risk of lung cancer. Stratified analyses by smoking history and cancer subtypes were also performed.Measurements and Main Results: Our study included 16,901 cases and 20,965 control subjects. Lung cancer odds ratios ranged from 1.15 (95% confidence interval, 1.04-1.27) to 1.45 (95% confidence interval, 1.31-1.60) for groups with the lowest and highest cumulative exposure, respectively. Increasing cumulative silica exposure was associated (P trend < 0.01) with increasing lung cancer risks in nonsilicotics and in current, former, and never-smokers. Increasing exposure was also associated (P trend ≤ 0.01) with increasing risks of lung adenocarcinoma, squamous cell carcinoma, and small cell carcinoma. Supermultiplicative interaction of silica exposure and smoking was observed on overall lung cancer risks; superadditive effects were observed in risks of lung cancer and all three included subtypes.Conclusions: Silica exposure is associated with lung cancer at low exposure levels. An exposure-response relationship was robust and present regardless of smoking, silicosis status, and cancer subtype.
650    _2
$a adenokarcinom plic $x epidemiologie $7 D000077192
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a malobuněčný karcinom $x epidemiologie $7 D018288
650    _2
$a spinocelulární karcinom $x epidemiologie $7 D002294
650    _2
$a kouření cigaret $7 D000073865
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a inhalační expozice $7 D019570
650    _2
$a nádory plic $x epidemiologie $x patologie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pracovní expozice $x statistika a číselné údaje $7 D016273
650    12
$a oxid křemičitý $7 D012822
650    _2
$a silikóza $x epidemiologie $7 D012829
651    _2
$a Kanada $x epidemiologie $7 D002170
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Peters, Susan $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
700    1_
$a Olsson, Ann $u International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France.
700    1_
$a Portengen, Lützen $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
700    1_
$a Schüz, Joachim $u International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France.
700    1_
$a Almansa, Josué $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
700    1_
$a Behrens, Thomas $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr University, Bochum, Germany.
700    1_
$a Pesch, Beate $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr University, Bochum, Germany.
700    1_
$a Kendzia, Benjamin $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr University, Bochum, Germany.
700    1_
$a Ahrens, Wolfgang $u Leibniz Institute for Prevention Research and Epidemiology-Bremen Institute for Prevention Research and Social Medicine (BIPS), Bremen, Germany.
700    1_
$a Bencko, Vladimir $u Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Benhamou, Simone $u Inserm Unit 1018, Villejuif, France.
700    1_
$a Boffetta, Paolo $u Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
700    1_
$a Bueno-de-Mesquita, Bas $u The National Institute for Public Health and Environmental Protection, Bilthoven, the Netherlands.
700    1_
$a Caporaso, Neil $u National Cancer Institute, Bethesda, Maryland.
700    1_
$a Consonni, Dario $u Unità di epidemiologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
700    1_
$a Demers, Paul $u Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Ontario, Canada.
700    1_
$a Fabiánová, Eleonóra $u Regional Authority of Public Health, Banská Bystrica, Slovakia. Faculty of Health, Catholic University, Ružomberok, Slovakia.
700    1_
$a Fernández-Tardón, Guillermo $u Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Institute of Health Research of the Principality of Asturias-Foundation for Biosanitary Research of Asturias (ISPA-FINBA), Faculty of Medicine, University of Oviedo, Oviedo, Spain.
700    1_
$a Field, John $u Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom.
700    1_
$a Forastiere, Francesco $u Consiglio Nazionale delle Ricerche-Istituto per la Ricerca e l'Innovazione Biomedica (CNR-Irib), Palermo, Italy.
700    1_
$a Foretova, Lenka $u Masaryk Memorial Cancer Institute, Brno, Czech Republic.
700    1_
$a Guénel, Pascal $u Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, Inserm Unit 1018, University Paris-Saclay, Villejuif, France.
700    1_
$a Gustavsson, Per $u The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
700    1_
$a Ho, Vikki $u University of Montreal Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada.
700    1_
$a Janout, Vladimir $u Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
700    1_
$a Jöckel, Karl-Heinz $u Institute for Medical Informatics, Biometry, and Epidemiology, University of Duisburg-Essen, Essen, Germany.
700    1_
$a Karrasch, Stefan $u Institute and Outpatient Clinic for Occupational, Social, and Environmental Medicine, Inner City Clinic, University Hospital of Munich and. Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany. Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, Munich, Neuherberg, Germany.
700    1_
$a Landi, Maria Teresa $u National Cancer Institute, Bethesda, Maryland.
700    1_
$a Lissowska, Jolanta $u The M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
700    1_
$a Luce, Danièle $u Université de Rennes I, Inserm Unit 1085, École des hautes études en santé publique (EHESP), Institut de recherche en santé, environnement et travail (Irset), Pointe-à-Pitre, France.
700    1_
$a Mates, Dana $u National Institute of Public Health, Bucharest, Romania.
700    1_
$a McLaughlin, John $u Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
700    1_
$a Merletti, Franco $u Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy.
700    1_
$a Mirabelli, Dario $u Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy.
700    1_
$a Plato, Nils $u The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
700    1_
$a Pohlabeln, Hermann $u Leibniz Institute for Prevention Research and Epidemiology-Bremen Institute for Prevention Research and Social Medicine (BIPS), Bremen, Germany.
700    1_
$a Richiardi, Lorenzo $u Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy.
700    1_
$a Rudnai, Peter $u National Public Health Center, Budapest, Hungary.
700    1_
$a Siemiatycki, Jack $u University of Montreal Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada.
700    1_
$a Świątkowska, Beata $u The Nofer Institute of Occupational Medicine, Lodz, Poland.
700    1_
$a Tardón, Adonina $u Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Institute of Health Research of the Principality of Asturias-Foundation for Biosanitary Research of Asturias (ISPA-FINBA), Faculty of Medicine, University of Oviedo, Oviedo, Spain.
700    1_
$a Wichmann, Heinz-Erich $u Institut für Medizinische Informatik Biometrie Epidemiologie, Ludwig-Maximilians-Universität, Munich, Germany. Institut für Epidemiologie, Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; and.
700    1_
$a Zaridze, David $u Russian Cancer Research Centre, Moscow, Russia.
700    1_
$a Brüning, Thomas $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance-Institute of the Ruhr University, Bochum, Germany.
700    1_
$a Straif, Kurt $u International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France.
700    1_
$a Kromhout, Hans $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
700    1_
$a Vermeulen, Roel $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
773    0_
$w MED00000297 $t American journal of respiratory and critical care medicine $x 1535-4970 $g Roč. 202, č. 3 (2020), s. 412-421
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32330394 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152659 $b ABA008
999    __
$a ok $b bmc $g 1608289 $s 1119134
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 202 $c 3 $d 412-421 $e 20200801 $i 1535-4970 $m American journal of respiratory and critical care medicine $n Am J Respir Crit Care Med $x MED00000297
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...